Effect of pH and Glucose on Cultured Human Peritoneal Mesothelial Cells

REFERENCES

• Jones A, Gahl GM, Frei U. Peritoneal dialysis fluid biocompatibility: does it really matter? Kidney Int 1994; 46(Suppl 48): S79–86.
   Google Scholar
• Dobbie JVV, Zaki M, Wilson L. Ultrastructural studies on the peritoneum with special reference to chronic ambulatory peritoneal dialysis. Scott Med J 1981; 26: 213–23.
   Google Scholar
• Di Paolo N, Sacchi G, De Mia M, Gaggiotti E, Capotondo L, Rossi P. et al. Morphology of the peritoneal membrane during continuous ambulatory peritoneal dialysis. Nephron 1986; 44: 204–11.
   PubMed Web of Science ®Google Scholar
• Pollock CA, Ibels LS, Eckstein RP, Graham JC, Caterson RJ, Mahony JF, et al. Peritoneal morphology on maintenance dialysis. Am J Nephrol 1989; 9: 198–204.
   PubMed Web of Science ®Google Scholar
• Gotloib L, Shostack A, Bar-Sella P, Cohen R. Continuous mesothelial injury and regeneration during long term peritoneal dialysis. Pent Dial Bull 1987; 7: 148–55.
   Google Scholar
• Topley N, Alobaidi 111VIM, Davies M, Coles GA, Williams JD, Lloyd D, et al. The effect of dialysate on peritoneal phagocyte oxidative metabolism. Kidney Int 1988; 34: 404–11.
   Google Scholar
• Coles GA, Lewis SL, Williams JD. Host defence and effects of solutions on peritoneal cells. In: Gokal R, Nolph KD, editors. The textbook of peritoneal dialysis. The Netherlands: Kluwer Academic Publishers, 1994: 503–28.
   Google Scholar
• Dobbie JVV, Lloyd JK, Gall CA. Categorization of ultrastructural changes in peritoneal mesothelium, stroma and blood vessels in uremia and CAPD patients. Adv Petit Dial 1990; 6: 3–12.
   Google Scholar
• Dobbie JW. Morphology of the peritoneum in CAPD. Blood Purif 1989; 7: 74–85.
   PubMed Web of Science ®Google Scholar
• Gotch FA. Adequacy of peritoneal dialysis. Am J Kidney Dis 1993; 21: 96–8.
   PubMed Web of Science ®Google Scholar
• Quarello F, Bonello F, Boero R, Maffei S, Beltrame G, Belardi P. et al. CAPD in a large population: a 7-year experience. Adv Pent Dial 1989; 5: 56–62.
   PubMedGoogle Scholar
• van Bronswijk H, Verbrugh HA, Bos HJ, Heezius ECJM, Oe PL, van der Meulen J, et al. Cytotoxic effects of commercial continuous ambulatory peritoneal dialy-sis (CAPD) fluids and of bacterial exoproducts on human mesothelial cells in vitro. Pent Dial Int 1989; 9: 197–202.
   Google Scholar
• Topley N, Mackenzie R, Petersen MM, Beavis MJ, Williams JD, Thomas N, et al. In vitro testing of a potentially biocompatible continuous ambulatory peri-toneal dialysis fluid. Nephrol Dial Transplant 1991; 6: 574–81.
   PubMed Web of Science ®Google Scholar
• Jones A, Topley N, Gahl GM. Biocompatibility of peritoneal dialysis fluids. Int J Artif Organs 1992; 15: 79–83.
   PubMed Web of Science ®Google Scholar
• Breborowicz A, Rodela H, Oreopoulos DG. Toxicity of osmotic solutes on human mesothelial cells in vitro. Kidney Int 1992; 41: 1280–5.
   Google Scholar
• Holmes CJ. Biocompatibility of peritoneal dialysis solutions. Pent Dial Int 1993; 13: 88–94.
   PubMed Web of Science ®Google Scholar
• Witowski J, Breborowicz A, Knapowski J, Oreopoulos D. In vitro culture of human peritoneal mesothelium for investigation of mesothelial dysfunction during peritoneal dialysis. J Physiol Pharmacol 1994; 45: 271–84.
   PubMedGoogle Scholar
• Wieslander AP, Nordin MK, Kjellstrand PTT, Boberg UC. Toxicity of peritoneal dialysis fluids on cultured fibroblasts, L-929. Kidney Int 1991; 40: 77–9.
   PubMed Web of Science ®Google Scholar
• Wieslander AP, Nordin MK, Martinson E, Kjellstrand PTT, Boberg UC. Heat sterilized PD-fluids impair growth and inflammatory responses of cultured cell lines and human leukocytes. Clin Nephrol 1993; 39: 343–8.
   Google Scholar
• Wieslander A, Linden T. Glucose degradation and cytotoxicity in PD fluids. Petit Dial Int 1996; 16(Suppl 1): S114–8.
   PubMedGoogle Scholar
• Rippe B, Krediet RT. Peritoneal physiology-transport of solutes. In: Gokal R, Nolph KD, editors. The textbook of peritoneal dialysis. The Netherlands: Kluwer Aca-demic Publishers, 1994: 69–113.
   Google Scholar
• Di Paolo N. The peritoneal mesothelium: an excretory organ. Petit Dial Int 1989; 9: 151–3.
   PubMed Web of Science ®Google Scholar
• Van Hinsbergh VWM, Kooistra T, Scheffer MA, van Bockel JH, van Muijen GNP. Characterization and fibrinolytic properties of human omental tissue meso-thelial cells. Comparison with endothelial cells. Blood 1990; 75: 1490–7.
   Google Scholar
• Sitter T, Toet K, Fricke H, Schiffl H, Held E, Kooistra T. Modulation of procoagulant and fibrinolytic system components of mesothelial cells by inflammatory mediators. Am J Physiol 1996; 271: R1256–63.
   PubMed Web of Science ®Google Scholar
• Pronk A, de Groot PG, Hoynck van Papendrecht AAGM, Verbrugh HA, Leguit P. van Vroonhoven TJMV, et al. Thrombogenicity and procoagulant activity of human mesothelial cells. Arterioscler Thromb 1992; 12: 1428–36.
   PubMed Web of Science ®Google Scholar
• Baricos WH, Shah SV. Proteolytic enzymes as media-tors of glomerular injury. Kidney Int 1991; 40: 161–73.
   PubMed Web of Science ®Google Scholar
• Stylianou E, Jenner LA, Davies M, Coles GA, Williams JD. Isolation, culture and characterization of human peritoneal mesothelial cells. Kidney Int 1990; 37: 1563–70.
   Google Scholar
• Gressner AM, Lahme B, Roth S. Attenuation of TGF-t,-induced apoptosis in primary cultures of hepatocytes by calpain inhibitors. Biochem Biophys Res Commun 1997; 231: 457–62.
   Google Scholar
• Takenouchi T, Munekata E. Trophic effects of substance P and Pamyloid peptide on dibutyryl cyclic AMP-differentiated human leukemic (HL-60) cells. Life Sci 1995; 56: PL479–84.
   PubMed Web of Science ®Google Scholar
• Verger C, Luger A, Moore HL, Nolph KD. Acute changes in peritoneal morphology and transport proper-ties with infectious peritonitis and mechanical injury. Kidney Int 1983; 23: 823–31.
   PubMed Web of Science ®Google Scholar
• Slater ND, Cope GH, Raftery AT. Mesothelial hyper-plasia in response to peritoneal dialysis fluid: a morphometric study in the rat. Nephron 1991; 58: 466–71.
   Google Scholar
• Gries E, Kopp J, Thomae U, Kuhlmann H. Relation of intraperitoneal and intravascular coagulation and fibri-nolysis related antigens in peritoneal dialysis. Thromb Haemost 1990; 63: 356–60.
   PubMed Web of Science ®Google Scholar
• Kreisberg JI. Biology of disease: hyperglycemia and microangiopathy. Direct regulation by glucose of microvascular cells. Lab Invest 1992; 67: 416–26.
   Google Scholar
• Dobbie JW. Pathogenesis of peritoneal fibrosing syn-dromes (sclerosing peritonitis) in peritoneal dialysis. Petit Dial Int 1992; 12: 14–27.
   PubMed Web of Science ®Google Scholar
• Whitaker D, Papadimitriou JM, Walters MNI. The mesothelium: its fibrinolytic properties. J Pathol 1982; 136: 291–9.
   Google Scholar
• Myhre-Jensen O, Larsen SB, Astrup T. Fibrinolytic activity in serosal and synovial membranes. Rats, guinea pigs, and rabbits. Arch Pathol 1969; 88: 623–30.
   Google Scholar
• Porter JM, McGregor Jr FH, Mullen DC, Silver D. Fibrinolytic activity of mesothelial surfaces. Surg Forum 1969; 20: 80–2.
   PubMedGoogle Scholar
• Topley N, Kaur D, Petersen MM, Roues A, Passlick-Deetjen J, Coles GA, et al. Biocompatibility of bicarbonate buffered peritoneal dialysis fluids: influence on mesothelial cell and neutrophil function. Kidney Int 1996; 49: 1447–56.
   Google Scholar